Endonovo Therapeutics Inc (ENDV)

[GetSeriousOK]

Thanks for all the info!

I think all the Assisi Loop clinical data is from Endonovo. I don't think ZoMedica has done any new clinicals since buying the Assisi Loop.

[Craig305]

The Assissi Loop references to many Sofpulse clinicals in the past years due to being the same technology. The only difference they have is that the Assissi Loop has a thicker rubber covering over the loop. Is more sturdy for use with animals. I believe Assissi has done their own clinicals also but I do not have any of that specific info at the current time. 

I do not have the links to the old clinicals anymore. Lost that info with my old phone.

I'm sure Rhode and Rohde are the same person. Appears to be an easy misspelling.

Yes, I agree. Most definitely the clinical trials have been way too small.

[GetSeriousOK]

Were all those referenced clinicals done using the Assisi Loop?

Don't suppose you have links to these clinical trials, especially "Strauch et al 2006?"

Also, is Rohde and Rhode the same person, with the name spelled differently? Kind of looks that way.

FYI, I think these tPEMF clinicals are all skewed by underpowered clinical trials (small sample sizes) and that's why the FDA clears the devices but the insurance companies remain skeptical.

Thanks!

[Craig305]

If you look at the document in this link, you will see Rohde had studied the Sofpulse in 2010/2012 and had positive results. Interesting how the more recent study showed no factor of improvement.

https://www.google.com/url?sa=t&source=web&rct=j&opi=89978449&url=https://www.petvetbiomed.com/html5/Web/10200/9%2520Assisi%2520Loop%2520-%2520Clinical%2520Overview.pdf&ved=2ahUKEwih0JDr07mJAxVISzABHcmTGmIQFnoECBYQAQ&usg=AOvVaw3h8B3JnQP30rBkWbvMeuPm

I have talked to people that swear by the technology and it's usefulness and/or effectiveness. Unfortunately, the scientific studies are mixed across the board and this is why the insurance companies do not support the cost.
The original Sofpulse, with the wired loops to a machine, were used for treating diabetic sores many years ago with the past ownership. 

PEMF continues to be studied by new groups of doctors and scientists. 
There is a private company using a device/technology very similar to Sofpulse for the treatment of Alzheimer's.  Will be interesting to see the results of that study when completed.


I spoke to a Dr. (years ago) that was convinced PEMF treatments most definitely assist with treating Alzheimer's. He just never did any true scientific studies and he was using a different PEMF device.

[GetSeriousOK]

Interesting. I couldn't find that Christine Rhode study at first, but then I figured out that it's Rohde, not Rhode. Christine RHODE returns a lot of results! What an odd coincidence.

Anyway I see that the NCT number is NCT03360214

https://www.clinicaltrials.gov/study/NCT03360214?tab=history&a=7#version-content-panel

Underpowered trial. Results make it look like the PEMF placebo group had less pain than the Active PEMF group.

Same thing happened to Ilfeld in his ActiPatch opioid study. Underpowered trial. Results make it look like the PEMF placebo group had less pain than the Active PEMF group.

Disclaimer: I'm not buying BIEL or ENDV. I just like doing the DD.

[Craig305]

ENDV misses all timelines. Is best not to have any expectations and continue to be disappointed. The Abrams orthopedic study has been postponed and delayed multiple times. 

A study, not sponsored by ENDV, but using the Sofpulse by Christine Rhode, produced no noticeable advantages of using Sofpulse after mastectomy procedure.

Ilfeld's study might be the last saving spark ENDV needs to stay alive.  

[GetSeriousOK]

Curious as to why nobody is talking about Dr. Ilfeld's SofPulse clinical trial and its possible relation to the NOPAIN Act. Maybe it's because everyone here is BEARISH so there's nobody saying anything positive? I can certainly understand that if it's the case.

The NOPAIN Act was kind of all the BIEL shareholders talked about for months, although they are quiet about it now.

Here's Ilfeld's SofPulse trial. It just finished on Oct. 20th -- expecting results by the end of the year.

https://clinicaltrials.gov/study/NCT05796583

[John_Vallay]

Endonovo management has not done anything illegal and that is the reason they have not been thrown in jail.
Unfortunately most investors do not understand real-world-investing. Especially penny-stock-investing.

For a legal case to be brought up against Alan Collier the government must show what Collier did illegal. I do not see anything illegal. I see immoral acts by Collier. I see stupid acts by Collier. I see mistakes by Collier, nut I do not see illegal.

[Craig305]

Q3 has ended and the roadmap catalysts for Q1, Q2, and Q3 have not happened.
Just saying.

[mrfumbles]

Pure garbage

[brojazzy]

Have these con artists been thrown into jail yet?

[Craig305]

UNITED STATES OF AMERICA

BEFORE THE

SECURITIES AND EXCHANGE COMMISSION

September 19, 2024
__________________________________

In the Matter of

Endonovo Therapeutics, Inc. 6320 Canoga Avenue, 15th Floor Woodland Hills, CA 91367

ORDER DECLARING OFFERING STATEMENT ABANDONED UNDER THE SECURITIES ACT OF 1933, AS AMENDED

File No: 024-11805
__________________________________

Endonovo Therapeutics, Inc. filed with the Commission an offering statement to qualify an offering of securities under Section 3(b) of the Securities Act of 1933. The offering statement has been on file for more than nine months and has not yet been qualified.

In view of the foregoing, it is ORDERED that the offering statement be declared abandoned on September 19, 2024.

For the Commission, by the Division of Corporation Finance, pursuant to delegated authority.

[Craig305]

We are in the last month of Q3 and the Q1 and Q2 catalysts have not come to fruition.
Q3 roadmap shows the spin-off of medical device assets and IP to Sofpulse is supposed to happen.

[ScambusterBrown]

I'm the Jackie in that cited post. Want to have a private conversation with you. This site won't let me send you a private message without joining. Can you send me a private message so we can set up a time to talk? I have info that isn't public but there should definitely be a bigger expose on the duo of Collier & Kann.

[Craig305]

Q2 Earnings Report has been released.
$10k of revenue for Q2.
Evermed was supposed to have a target of $25k per the 8K.
Don Calabria is not keeping up with his end of the published sales to Costa Rica and Mexico either.

[brojazzy]

I sure don't miss the days of trading the OTC, scams all over the place and this is one's at the top

[Craig305]

Today's volume was the result of a tweet.
Only said "Future NASDAQ IPO coming".
No timeframe or details.
Feel sorry for those that bought at .0016, 17, 18 and get immediately dumped on to close at .0010. 😯.

[Craig305]

Roadmap update.

Q2 was supposed to complete the Reg A with raising $5 million.
Website updates were supposed to be completed.
Telehealth division was supposed to be launched.

Anyone see any updates regarding any of those catalysts? Didn't think so.

[brojazzy]

Is mgmt in prison yet?

[brojazzy]

Just checked in, yep, still a pile of steaming shit

[Craig305]

Held at DTC Shares Updated:
🔴 176,772,058 (2024-05-24)
🟢 196,580,033 (2024-06-14)
Difference: +11.2% (+19M)

Outstanding Shares Updated:
🔴 377,019,970 (2024-05-24)
🟢 396,827,945 (2024-06-14)
Difference: +5.3% (+19M)

Unrestricted Shares Updated:
🔴 181,726,791 (2024-05-24)
🟢 201,534,766 (2024-06-14)
Difference: +10.9% (+19M)

[Craig305]

Outstanding Shares Updated:
- 🔴 From: 377,019,970 (377.02M - 5/24/2024)
- 🟢 To: 396,827,945 (396.83M - 6/14/2024)
(Diff: 19.81M, % Change: 5.254%)

[Craig305]

$ENDV

💰0.0013
Pink Current, AS: 2.5B, OS: 377M, US: 181M

Held at DTC Shares Updated:
🔴 150,896,445 (2024-05-03)
🟢 176,772,058 (2024-05-24)
Difference: +17.1% (+25M)

Outstanding Shares Updated:
🔴 349,394,357 (2024-05-03)
🟢 377,019,970 (2024-05-24)
Difference: +7.9% (+27M)

Restricted Shares Updated:
🔴 193,543,179 (2024-05-03)
🟢 195,293,179 (2024-05-24)
Difference: +0.9% (+1.8M)

Unrestricted Shares Updated:
🔴 155,851,178 (2024-05-03)
🟢 181,726,791 (2024-05-24)
Difference: +16.6% (+25M)

Chart, OTC Profile, Twitter, @otcupdates

[Craig305]

This $8K in revenue might be Evermed with their Q1 performance threshold requirement per the 8K.
Q2 is supposed to increase to $25K.

[Craig305]

Also sending prayers to the stuck shareholders that bought past $.01 thinking it would remain there and beyond.
Allowing this to go Pink and non reporting was the obvious sign Collier was going to allow this to spin down the drain.

[retired early]

Prayers for that NUDE bone removed mouse. He prayed this contraption would have grown his bone piece back and live on cheese and treadmill rehabilitations for the rest of his life. Even live to tell his grandchildren mice old lab stories. :(

[Craig305]

Q1 Report is released.
$8k revenue and no cash on hand.

[brojazzy]

When will this scam do another RS?

[Craig305]

Unrestricted shares increased by 11.7%
Going to be harder for people to get back to a higher share price with the float increasing at this high rate.

[Craig305]

Annual Report posted.
No $300K sales as stated in PR.
Donald Calabria...former COO of Endonovo is involved in Pulse and getting shares of ENDV to support a fake company.

Interesting how you can now see who is being given shares of stock in this Annual report.

At least ENDV will not end up on the Expert Market now.

[Craig305]

Based on a paid marketing article that was released by ENDV, there is a paragraph that states the following:

With the sale of the human medical rights and SofPulse® IP to SofPulse, Inc., Endonovo will turn its attention to other promising opportunities. Management intends to utilize groundbreaking multi-coil technology for over the counter PEMF product development in wellness and non-medical human markets while continuing to build their mergers and acquisitions division adding new IP and technology.

Wonder if this means ENDV will try to buy Micro-Pulse which is owned by Robert Dennis. Robert worked with Donnie Rudd on various projects in the past. Micro-Pulse has multi-coil products.
Of course this can only happen if ENDV can manage to raise funds with any of their capital raise offerings.

[Craig305]

Remember this announcement in the October 2021 letter to shareholders:

The Stanford University Clinical trial is being completed by Board certified Orthopedic surgeon Geoffrey Abrams, MD and is titled, “Pulsed Electromagnetic Field (PEMF) Therapy for Post-operative Pain”, is in recruitment stage with scheduled completion date of August 2023.

The completion date is now estimated at February 2025.

Goalpost has been moved a few times already.

[Craig305]

Donald was most certainly listed as part of Endonovo's team on their website for a few years. Just forget what title he was assigned.

[Craig305]

After more research, I see Pulse Therapeutics is a company with the officer of said company being Donald Calabria. It has the company address to his apartment in California.
Who is Donald Calabria?
He is an old friend of Alan's and can be found in the Hanover 10Qs receiving stock compensation for consulting services. I thought he might have also been involved with ENDV in the early stages. Can't remember now.
Point is....Pulse is not some independent company. Alan is most certainly behind the scene with Pulse and using that company for PR purposes to make it appear things are better than they really are.

[Craig305]

On Jan 26, 2023 ENDV released this PR
https://www.otcmarkets.com/stock/ENDV/news/Endonovo-Partners-with-International-Distributor-for-SofPulse-Line?id=387747

Coincidentally enough, that is the same day Pulse Therapeutics Technology became an operating company.
Most likely a company Alan or Ira coordinated into existence.

We have yet to see the $300k order hit the revenue of ENDV's financials. Will it show in the upcoming Annual? Will ENDV post the Annual?

If the testing and marketing of the initial $100k was so successful as of Jan 26, 2023....what have they been doing in the first 3Qs for the $300k order to not show up?

Follow the pattern....promises... positive news.....never actually materializes later.

I'm throwing out the challenge. Do due diligence on Pulse Therapeutics Technology and find out what they actually do or have done with Sofpulse. Find someone in MX or Costa Rica that is buying from them.

[Kjv]

I am in Canada so I can buy anything.

[Craig305]

Do you know if some brokerages (i.e. Schwab) stop allowing you to buy Pink Limited status stocks?

[Kjv]

Yup.
Saw that overnight

[Craig305]

ENDV is now changed to Pink Limited status on OTC Markets.

[Kjv]

Nah.

You don’t know me man.

[John_Vallay]

Kjv

Based on your reply, it would seem to me that you are looking for lightning to strike.
Your investment is based on impulse and dreams, not fundamentals.

You buy $10,000 worth of ENDV stock at .002 a share means you own 5 million shares.
If the stock reaches JUST 1 PENNY A SHARE, your 5 million shares are worth $50,000 which means you would be happy with a $40,000 profit.

You may also dream of the stock reaching 2 cents a share because it was close to 2 cents a year ago, which would mean your 5 million shares would be worth $100,000 and you net a $90,000 profit.

I do not wish you ill-will, but the chances of ENDV going to 0001 is much more probable than getting to your dream numbers.

Unfortunately in the OTC sub penny world, many investors have your philosophy and get burned most of the time, but maybe you will catch the lighting in a bottle and walk away a happy person with your ENDV investment, but in my opinion you are better off going to Las Vegas and putting your $10,000 on a HARD 8.

[Kjv]

Thank you.

I agree with your analysis and I do see it.

I have invested just enough to reflect I am just riding my luck.

We will see.

[Craig305]

The main people posting negative have been following this company since 2017.
This is not as simple as being sour grapes of buying high and never seeing a positive return.
There is a history of nothing ever being accomplished after positive and promising PRs are released to shareholders.
I believe John's challenge to you is to provide something positive about ENDV as a company and not just having luck on day trading.
If you believe the PRs of future catalysts are a positive....then good luck to you. No forward promises of the past have ever come to fruition with this company.
One needs to really analyze these future catalysts and determine how it will be possible to come true. Watch and see if any of the timelines actually get met.

[Kjv]

Been playing this for a while and I always recognize those bought high before a deep downward trend are more likely to point out the negatives

I have plays I bought high too and see how others are getting way cheaper!

Done some DD and taken my risk down here…we will see.

I appreciate you guys’s posts on here though…helped a lot!

[John_Vallay]

To Kjv

Did you write "It's not all doom and gloom"

What do you see as a positive. I am giving you an opportunity to say positive things about Endonovo the company and ENDV the stock.
While I am not going to engage in a confrontational message board back-and-forth with you, I am simply going to read your positivity about ENDV and not reply. Just looking for some reading here.

[Kjv]

Sorry I meant to say annual report.

Calling it 10K can be misleading. Companies just started to release annuals…so we will see.

It’s not all doom and gloom

[Craig305]

You might not call it an official 10K anymore, but an annual report is needed by OTC Markets if ENDV wishes to remain "current" status.
See requirements below.


Ongoing Requirements: To qualify for Current Information on an ongoing basis, companies must:
Publish reports through OTCIQ on the following schedule:
Quarterly Report within 45 days of the quarter end
Annual Report within 90 days of the fiscal year end
Attorney Letter within 120 days of the fiscal year end if financial statements are unaudited.
Maintain a Verified Profile. At least once every six months, review and verify the Company Profile through OTCIQ.
Maintain Transfer Agent Verified share data. If your transfer agent participates in the Transfer Agent Verified Shares Program, then your securities must have current share data verified by the transfer agent.
Maintain an Active standing in the Company’s State of Incorporation.


Pink Limited Information Tier
Companies that do not meet the requirements of the Pink Current Information tier set forth above may still qualify for the Pink Limited Information Tier by meeting the following minimum disclosure requirements.
Annual Financial Statements: Publish one set of Qualifying Annual Financial Statements which cover the past 2 completed fiscal years, provided the most recently completed fiscal year is within the past 16 months.

[Kjv]

You don’t file 10K if you are alternative reporting.
Form 15 was to stop SEC reporting.

So the next filing is quarterly not behind yet!

[Craig305]

ENDV still has to file 10k to remain compliant with OTC Markets standards.
They are now late.
Let's see how long it takes for Pink Limited status to appear.

[John_Vallay]

KARMA

That is the only thing I will say when thinking about Alan Collier

KARMA in one form or another will get Collier. Maybe it will be KARMA against Collier directly, or a loved one like his children or family member.

Collier can steal from people and he may think he is getting away with it, but at some point KARMA will get Collier through afflicting a loved one.

I know KARMA scares me even more than a jail cel. Most people are good people and do the right thing for many reasons, but ask psychiatrists and psychologists and they will tell you even good people need FEAR to dissuade them from doing something wrong or illegal.

Sometimes FEAR is the possibility of jail, embarrassment and sometimes KARMA. For me I like to think being just a good person is what makes me tick, but at times KARMA is what scares me the most. KARMA against my wife and especially against my kids is what keeps me on the straight and narrow.

Who knows the truth behind closed doors inside Colliers house or with his children now or in the future, but KARMA should be in Colliers mind if he has a soul.